CRMD today
$5.33+$0.03 (+0.57%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourBullish
1 hourStrong Bullish
15 minLeaning Bullish
5 minExpanding
Daily trend turns up above $15.38
Key levels
Resistance$6.56
Resistance$5.79
Support$5.30
Support$4.57
Latest news & SEC filings
EarningsCormedix holds Q3 2026 earnings call
EarningsCorMedix Posts Q3 2026 Results, Issues Business Update
SEC FilingCorMedix Inc. filed a report on a major company event (Form 8-K)
EarningsCormedix posts wider quarterly loss but revenue tops expectations
GuidanceCormedix reaffirms FY2026 sales guidance of $325M-$345M
All CRMD news →About CorMedix
CorMedix is a biopharmaceutical company that develops and sells therapies for serious infections. Its main product is a solution instilled into central venous catheters to prevent bloodstream infections in adult kidney failure patients receiving hemodialysis. The company also markets anti-infective products for hospital and clinic use, including REZZAYO, MINOCIN IV, VABOMERE, ORBACTIV, KIMYRSA, and BAXDELA, and the cardiovascular drug TOPROL-XL. It operates in the United States, serving dialysis centers, hospitals, and related care settings.
Based on the company's 10-K filed Mar 5, 2026.
Nasdaq · Healthcare
CorMedix Inc. (CRMD)
What Is the Price Target for CRMD?
SEPT Low Target
$14.00
SEPT Mid Target
$15.00
SEPT High Target
$15.00
Analyst Consensus
$15.00
Is CRMD a Buy or Sell Right Now?
Thesis
- •Revenue growing 617.0% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CRMD.
Start Free Trial →Is CRMD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$12.50
71
Moat Score
WIDE
5/9
Piotroski Score
1.0
Altman Z-Score
What Is Smart Money Doing with CRMD?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Dillione Janet | director | Buy | 48,909 | - | Sep 18, 2026 |
| Blum Susan | officer | Sale | 8,424 | $70K | Aug 29, 2026 |
| Hurlburt Elizabeth | officer | Sale | 8,076 | $67K | Aug 29, 2026 |
| Zelnick Kaufman Beth | officer | Sale | 8,424 | $70K | Aug 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CRMD Growth Story
Revenue YoY
617.0%
3yr Revenue CAGR
1077.5%
EPS Growth YoY
780%
FCF Growth YoY
440.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for CRMD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CRMD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:12:34 | $5.31 | 1,202 | $$6K | SELL |
| 15:12:00 | $5.34 | 3,092 | $$17K | BUY |
| 15:12:00 | $5.34 | 2,395 | $$13K | BUY |
| 15:11:59 | $5.34 | 1,872 | $$10K | BUY |
| 15:11:59 | $5.34 | 4,332 | $$23K | BUY |
5 dark pool trades shown · $$69K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About CRMD
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for CRMD. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$CRMD reports earnings before the open on Thu Nov 12. 📊
Zone Setup — $CRMD (CorMedix Inc.) Price: $7.83 | Zone: $7.10 — $8.98 Conviction: MEDIUM | Analyst upside: +83.5% Near resistance (39% of range) — breakout watch. Earnings: REVENUE_BEAT. Analyst tar...
Join 3,500+ traders discussing CRMD in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CorMedix Inc. (CRMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CRMD — frequently asked questions
What is CRMD stock price today?
CorMedix Inc. (CRMD) is at $5.33, up 0.57% (+$0.03) at the Nov 12, 2026 close.
Why is CRMD stock moving today?
Latest CRMD news — Nov 12, 2026: Cormedix holds Q3 2026 earnings call · Nov 12, 2026: CorMedix Posts Q3 2026 Results, Issues Business Update
Why did CRMD stock move on Nov 2, 2026?
CorMedix shares fell 5.44% to close at $5.39 on volume of about 3.23 million shares, trading between a low of $5.34 and a high of $5.75. Needham restated its Buy rating but cut its price target to $12, while the company filed a Form 8-K disclosing a major company event.
What is the CRMD price target?
The average analyst price target for CRMD is $15.00, ranging from $14 to $15, based on 5 analysts. Latest: Needham maintains on Nov 10, 2026.
What do analysts rate CRMD?
Analyst ratings for CRMD: 1 Buy, 10 Hold, 0 Sell — consensus Hold.
Did CRMD beat earnings?
CRMD last reported on Aug 13, 2026: EPS $0.29 vs $0.24 expected — a beat of 21.8%.
What is CRMD's P/E ratio?
CRMD trades at a P/E of 2.4 vs a Healthcare average of 17.7.
Does CRMD pay a dividend?
CRMD does not currently pay a dividend.
What are CRMD support and resistance levels?
Support: $5.30, $4.57, $3.90. Resistance: $5.79, $6.56, $7.16.
What are insiders doing with CRMD?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on CRMD?
Nov 12, 2026: Cormedix holds Q3 2026 earnings call · Nov 12, 2026: CorMedix Posts Q3 2026 Results, Issues Business Update · Nov 12, 2026: CorMedix Inc. filed a report on a major company event (Form 8-K)